BOUDREAUX GAIL (President and CEO) purchased 1.6% of their position (2.73K shares) of ELEVANCE HEALTH, INC. on the open market
Open‑market purchase worth $1.00M — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/17/2026ACC: 0001287920-26-000006
DirectorOfficer· President and CEO
Since Mar 2026
+2.73K
Net shares
Net buyer
$1.00M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2.73K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+680.00
Price / share
$366.41
Trade value
$249.16K
% of position
0.4%
7/17/2026
169.25K→169.93K
Common Stock
Direct
Shares
+2.04K
Price / share
$368.25
Trade value
$753.07K
% of position
1.2%
7/17/2026
169.93K→171.98K
Total
Net shares
+2.73K
Net value
$1M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/17/2026 | P · Purchase | +680.00 | $366.41 | $249.16K | 0.4% | 169.25K | 169.93K |
| Common Stock Direct | 7/17/2026 | P · Purchase | +2.04K | $368.25 | $753.07K | 1.2% | 169.93K | 171.98K |
| Total | +2.73K | $1M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned60.00
Total
60.00 indirect60.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60.00 | Indirect |
| Total | 60.00 | 60.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported